GLOW

Description: GLOW is a multi-component peptide blend that typically combines GHK-Cu, a copper-binding glycyl-histidyl-lysine tripeptide, with BPC-157, a synthetic pentadecapeptide, and TB-500, a thymosin beta-4-derived actin-binding fragment. As a formulated blend rather than a single molecular entity, it has no defined molecular formula or weight. In laboratory and preclinical models it is investigated for convergent extracellular-matrix remodeling, angiogenesis, and fibroblast-mediated tissue-repair pathways, with attention to collagen synthesis, endothelial and vascular signaling, and actin-dependent cell migration. The combination is frequently studied to characterize potential synergistic mechanisms across the individual peptide components.

For Research Use Only.